This is the authors' abstract. We don't add key points for this paper.
We performed genomic analyses and in vitro experiments in a collection of bacterial and fungal strains. We identified a combination (SBD111-A) that produced high levels of SCFA in vitro and protected against ovariectomy-induced bone loss in a dose-dependent manner in mice. Metagenomic sequencing revealed that SBD111-A changed the taxonomic composition and function of the gut microbiome and enriched pathways for synthesis of bone-protective SCFA, vitamin K2, and branched-chain amino acids.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Lawenius et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: